Prostate cancer diagnosis: an immunological aspects

Introduction. Contemporary diagnosis of prostate cancer is crucial to the patient’s further fate. Difficulties in the histological verification of the final diagnosis and false-negative results of biopsy research are often associated with the similarity of the prostate adenocarcinoma`s micromorpholo...

Full description

Bibliographic Details
Main Authors: S. V. Popov, R. G. Guseinov, I. N. Orlov, V. V. Protoshchak, O. N. Skryabin, P. A. Babkin, F. A. Bagrov, A. S. Katunin, A. G. Martov, V. L. Schukin
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2019-02-01
Series:Vestnik Urologii
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/235
_version_ 1797272180906524672
author S. V. Popov
R. G. Guseinov
I. N. Orlov
V. V. Protoshchak
O. N. Skryabin
P. A. Babkin
F. A. Bagrov
A. S. Katunin
A. G. Martov
V. L. Schukin
author_facet S. V. Popov
R. G. Guseinov
I. N. Orlov
V. V. Protoshchak
O. N. Skryabin
P. A. Babkin
F. A. Bagrov
A. S. Katunin
A. G. Martov
V. L. Schukin
author_sort S. V. Popov
collection DOAJ
description Introduction. Contemporary diagnosis of prostate cancer is crucial to the patient’s further fate. Difficulties in the histological verification of the final diagnosis and false-negative results of biopsy research are often associated with the similarity of the prostate adenocarcinoma`s micromorphological picture and its benign lesions.Purpose of the study. Comprehending the possibilities of immunohistochemical identification of tumor cells and the basal epithelial layer of prostate glandular structures in prostate cancer suspected cases.Materials and methods. A biopsy material was taken from 134 patients. Prostate adenocarcinoma was verified by routine histological examination in 72 samples, in 62 samples there were no signs of malignant transformation. Subsequently, immunohistochemical analysis of biopsy specimens was performed using antibodies to α-methylacyl-CoA racemase, nuclear p63 protein and high-molecular cytokeratin.Results. The AMACR-positive reaction of malignant cells and a negative reaction of the basal epithelium to nuclear p63 protein antibodies and high-molecular cytokeratin were detected during prostate adenocarcinoma.Conclusion. If prostate cancer is suspected, immunohistochemical assays with monoclonal antibodies to AMACR, p63 and high-molecular cytokeratin greatly facilitate the detection of adenocarcinoma.
first_indexed 2024-03-07T14:24:42Z
format Article
id doaj.art-dc34432ea94e4de69534ebaf82f4fa20
institution Directory Open Access Journal
issn 2308-6424
language Russian
last_indexed 2024-03-07T14:24:42Z
publishDate 2019-02-01
publisher State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
record_format Article
series Vestnik Urologii
spelling doaj.art-dc34432ea94e4de69534ebaf82f4fa202024-03-06T08:56:03ZrusState Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian FederationVestnik Urologii2308-64242019-02-0164424810.21886/2308-6424-2018-6-4-42-48181Prostate cancer diagnosis: an immunological aspectsS. V. Popov0R. G. Guseinov1I. N. Orlov2V. V. Protoshchak3O. N. Skryabin4P. A. Babkin5F. A. Bagrov6A. S. Katunin7A. G. Martov8V. L. Schukin9Clinical Hospital of St. Luke.Clinical Hospital of St. Luke.Clinical Hospital of St. Luke.Military medical academy of S.M. Kirov.Clinical Hospital of St. Luke.Military medical academy of S.M. Kirov.Clinical Hospital of St. Luke.Clinical Hospital of St. Luke.State Research Center – Burnasyan Federal Medical Biophysical Center.The City Hospital No. 20.Introduction. Contemporary diagnosis of prostate cancer is crucial to the patient’s further fate. Difficulties in the histological verification of the final diagnosis and false-negative results of biopsy research are often associated with the similarity of the prostate adenocarcinoma`s micromorphological picture and its benign lesions.Purpose of the study. Comprehending the possibilities of immunohistochemical identification of tumor cells and the basal epithelial layer of prostate glandular structures in prostate cancer suspected cases.Materials and methods. A biopsy material was taken from 134 patients. Prostate adenocarcinoma was verified by routine histological examination in 72 samples, in 62 samples there were no signs of malignant transformation. Subsequently, immunohistochemical analysis of biopsy specimens was performed using antibodies to α-methylacyl-CoA racemase, nuclear p63 protein and high-molecular cytokeratin.Results. The AMACR-positive reaction of malignant cells and a negative reaction of the basal epithelium to nuclear p63 protein antibodies and high-molecular cytokeratin were detected during prostate adenocarcinoma.Conclusion. If prostate cancer is suspected, immunohistochemical assays with monoclonal antibodies to AMACR, p63 and high-molecular cytokeratin greatly facilitate the detection of adenocarcinoma.https://www.urovest.ru/jour/article/view/235prostate adenocarcinomabiopsyfalse-negative resultsamacrp6334βe12
spellingShingle S. V. Popov
R. G. Guseinov
I. N. Orlov
V. V. Protoshchak
O. N. Skryabin
P. A. Babkin
F. A. Bagrov
A. S. Katunin
A. G. Martov
V. L. Schukin
Prostate cancer diagnosis: an immunological aspects
Vestnik Urologii
prostate adenocarcinoma
biopsy
false-negative results
amacr
p63
34βe12
title Prostate cancer diagnosis: an immunological aspects
title_full Prostate cancer diagnosis: an immunological aspects
title_fullStr Prostate cancer diagnosis: an immunological aspects
title_full_unstemmed Prostate cancer diagnosis: an immunological aspects
title_short Prostate cancer diagnosis: an immunological aspects
title_sort prostate cancer diagnosis an immunological aspects
topic prostate adenocarcinoma
biopsy
false-negative results
amacr
p63
34βe12
url https://www.urovest.ru/jour/article/view/235
work_keys_str_mv AT svpopov prostatecancerdiagnosisanimmunologicalaspects
AT rgguseinov prostatecancerdiagnosisanimmunologicalaspects
AT inorlov prostatecancerdiagnosisanimmunologicalaspects
AT vvprotoshchak prostatecancerdiagnosisanimmunologicalaspects
AT onskryabin prostatecancerdiagnosisanimmunologicalaspects
AT pababkin prostatecancerdiagnosisanimmunologicalaspects
AT fabagrov prostatecancerdiagnosisanimmunologicalaspects
AT askatunin prostatecancerdiagnosisanimmunologicalaspects
AT agmartov prostatecancerdiagnosisanimmunologicalaspects
AT vlschukin prostatecancerdiagnosisanimmunologicalaspects